Gilead Sciences (GILD) Gains from Investment Securities (2013 - 2015)

Gilead Sciences (GILD) has 3 years of Gains from Investment Securities data on file, last reported at $2.0 million in Q1 2015.

• Quarterly Gains from Investment Securities fell 33.33% year-over-year to $2.0 million in Q1 2015, while the trailing twelve-month figure through Mar 2015 was $21.0 million (down 62.48% YoY) and the FY2014 annual result came in at $22.0 million, down 62.71% from the prior year.
• Gains from Investment Securities slipped to $2.0 million in Q1 2015, from $26.1 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $30.0 million in Q3 2013 to a low of -$12.1 million in Q3 2014.
• A 3-year average of $9.2 million and a median of $6.0 million in 2013 frame the typical range for Gains from Investment Securities.
• The widest YoY moves for Gains from Investment Securities: up 125.98% in 2014, down 140.28% in 2014.
• Tracing GILD's Gains from Investment Securities over 3 years: stood at $11.6 million in 2013, then soared by 125.98% to $26.1 million in 2014, then tumbled by 92.34% to $2.0 million in 2015.
• The last three Gains from Investment Securities figures came in at $2.0 million (Q1 2015), $26.1 million (Q4 2014), and -$12.1 million (Q3 2014), per Business Quant data.